SIBN News and Press, SI-BONE Inc. From 04/18/22

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Mond...

The following slide deck was published by SI-BONE, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: SI-BONE, Inc. 2021 Q4 - Results - Earnings Call Presentation

SI-BONE, Inc. (SIBN) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Matt Basco - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Kyle Rose - C...

SI-BONE press release (NASDAQ:SIBN): Q4 GAAP EPS of -$0.43 misses by $0.05. Revenue of $25.2M (+13.8% Y/Y) beats by $0.39M. For further details see: SI-BONE GAAP EPS of -$0.43 misses by $0.05, revenue of $25.2M beats by $0.39M

SANTA CLARA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2021. Recent High...

SANTA CLARA, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year 2021 after market cl...

SANTA CLARA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited rev...

SANTA CLARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced management is scheduled to participate in the following investor con...

SANTA CLARA, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that Blue Cross Blue Shield Association (BCBSA) Evidence Street ...

The following slide deck was published by SI-BONE, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: SI-BONE, Inc. 2021 Q3 - Results - Earnings Call Presentation